The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis

BACKGROUND: Early detection of iron-deficiency anemia (IDA) can enhance the efficiency and effectiveness of clinical treatment and quality of life for end-stage renal disease (ESRD) patients. This study aimed to evaluate the validity of CHr and %Hypo in screening IDA among ESRD patients and compare...

Descripción completa

Detalles Bibliográficos
Autores principales: Dinh, Nhan Hieu, Cheanh Beaupha, Suzanne Monivong, Tran, Loan Thi Anh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178621/
https://www.ncbi.nlm.nih.gov/pubmed/32321449
http://dx.doi.org/10.1186/s12882-020-01796-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178621/
https://www.ncbi.nlm.nih.gov/pubmed/32321449
http://dx.doi.org/10.1186/s12882-020-01796-8

Ejemplares similares